治疗向ATR的新型细胞功能:从胚胎发生到瘤发生
Himadri Biswas1, Yetunde Makinwa1, Yue Zou1
1Department of Cell and Cancer Biology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USA.
DNA损伤反应调节器ATR激酶是一个有前途的癌症治疗点. ATR抑制剂单独和与其他治疗一起显示出有效性,目前正在进行的研究正在解决挑战.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- DNA损伤反应 (DDR) 对癌症进展和治疗疗效至关重要.
- ATR (ataxia telangiectasia突变和Rad3相关) 激酶是DDR通路的关键调节者.
- DDR通路的失调,特别是ATR,与各种癌症有关.
研究的目的:
- 审查ATR在癌症发展和治疗中的生物基础和功能意义.
- 评估在癌症治疗中针对ATR的治疗理由.
- 评估开发选择性ATR抑制剂及其当前应用的进展情况.
主要方法:
- 对ATR激酶及其在DNA损伤反应中的作用现有的文献的综述.
- 分析涉及ATR抑制剂的临床前和临床研究.
- 检查过去几十年选择性ATR抑制剂的发展情况.
主要成果:
- ATR抑制剂作为单一疗法和组合疗法表现出抗瘤活性.
- 抑制ATR可以提高化疗,放射和免疫疗法的疗效.
- 开发有效和选择性的ATR抑制剂已经取得了显著的进展.
结论:
- 在癌症治疗中,ATR激酶是经过验证的治疗标.
- ATR抑制剂为单疗法和组合疗法提供了一个有希望的策略.
- 解决ATR抑制剂开发和应用所面临的挑战对于临床成功至关重要.
更多相关视频
08:41Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
相关概念视频
DNA Damage can Stall the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
The Intrinsic Apoptotic Pathway
